JPRN-UMIN000012441
Completed
未知
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastases - MRgFUS treatment for painful bone metastases
Department of Orthopaedic Surgery, Kochi Medical School, Kochi University0 sites25 target enrollmentNovember 29, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Orthopaedic Surgery, Kochi Medical School, Kochi University
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who either \-Need surgical stabilization of the affected bony structure, OR \-Targeted tumor is at an impending fracture site, OR \-Patients with surgical stabilization of tumor site with metallic hardware 2\. More than 5 painful lesions, or more than 1 requiring immediate localized treatment 3\. Patients on dialysis 4\. Patients with life expectancy \< 3\-Months 5\. Patients with an acute medical condition (e.g., pneumonia, sepsis) that is expected to hinder them from completing this study 6\. Patients with unstable cardiac status including: \-Unstable angina pectoris on medication \-Patients with documented myocardial infarction within six months of protocol entry \-Congestive heart failure requiring medication (other than diuretic) \-Patients on anti\-arrhythmic drugs 7\. Patients with severe hypertension (diastolic BP \> 100 on medication) 8\. Patients with standard contraindications for MR imaging such as non\-MRI compatible implanted metallic devices including cardiac pacemakers, size limitations (weight \>113kilograms), etc. 9\. Patients with an active infection or severe hematological, neurological, or other uncontrolled disease 10\. Known intolerance or allergies to the MRI contrast agent (e.g. Gadolinium or Magnevist) including advanced kidney disease 11\. Karnofsky Performance Status (KPS) Score \< 60 12\. Severe cerebrovascular disease (multiple CVA or CVA within 6 months) 13\. Individuals who are not able or willing to tolerate the required prolonged stationary position during treatment (approximately 2 hrs.) 14\. Are participating or have participated in another clinical trial in the last 30 days 15\. Patients unable to communicate with the investigator and staff 16\. Patients with persistent undistinguishable pain (pain source unidentifiable) 17\. Patients who are pregnant or lactating 18\. Patients with severe coagulation abnormalities 19\. Any patients disqualified by a study physician because of medical, psychological or any other reason
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Clinical Study on the Effectiveness and Safety of Guanxinning Tablets on Coronary Heart Disease Complicated with Diabetic NephropathyITMCTR2100005416Affiliated Hospital of Hangzhou Normal University
Recruiting
Phase 2
The study of clinical effectiveness and safety of a combination of 0.4% minoxidil and 0.05% retinaldehyde nanoparticles solution for treatment of androgenetic alopeciaAndrogenetic alopeciaAndrogenetic AlopeciaFemale pattern hair lossTopical nanominoxidilTopical retinaldehyde nanoparticlesTCTR20201104003ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital30
Active, not recruiting
Not Applicable
Clinical study of the safety and effectiveness of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) as fillers in the treatment of lip thinness and wrinkles around the mouthISRCTN30768206Sinclair Pharma68
Completed
Not Applicable
Clinical study of the safety and effectiveness of the use of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) in the treatment of facial skin depressions of the mid-faceFor MaiLi Precise® treatment: mild to moderate nasolabial folds and/or subjects with mild to moderate tear trough. For MaiLi Define® treatment: moderate to severe nasolabial folds and/or moderate to severe marionette lines.Skin and Connective Tissue DiseasesISRCTN10761529Sinclair Pharma68
Completed
Not Applicable
A clinical study on the efficacy and safety of the scent of essential oils for depressiodepressive stateJPRN-UMIN000051570Okinawa Prefecture10